Trademark Overview
On Wednesday, January 14, 2026, a trademark application was filed for GLENMERE PHARMS with the United States Patent and Trademark Office. The USPTO has given the GLENMERE PHARMS trademark a serial number of 99593876. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, June 9, 2026. The GLENMERE PHARMS trademark is filed in the Education & Entertainment Services, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:
Educational services namely, providing and conducting classes, seminars, symposiums, conferences and workshops in the field of pharmaceutical product development of medicines, healthcare, and cancer treatment; instruction and training services, in the field of pharmaceutical product development of medicines and cancer treatments; education services relating to medicine, namely, providing and conducting classes, seminars, symposiums, conferences and workshops in the field of pharmaceutical product development of medicines, healthcare, and cancer treatment; organising and conducting seminars and conventions in the field of medicine; information, advisory and consultancy services in relation to all of the aforesaid services.
Scientific and technological services, namely, scientific research, analysis, testing in the field of medicines, healthcare, and cancer treatment, and research and design relating thereto; chemical analysis; chemical research; research and development of new products for others; research and development on the subject of pharmaceuticals; consultancy relating to pharmaceutical research and development; conducting clinical trials in the field of pharmaceuticals; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; information, advisory and consultancy services in relation to all of the aforesaid services.
Medical services, veterinary services, and medical analysis services for diagnostic and treatment purposes provided by medical laboratories; Pharmaceutical compounding services; Pharmaceutical advisory services, namely, providing pharmaceutical advice; Provision of pharmaceutical information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals; Providing information in the field of medicine; horticultural services; information, advisory and consultancy services in relation to all of the aforesaid
